People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| New Haven Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $18.9M | $18.7M | 2012 |
Rob Sterling at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rob Sterling on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Wagner | 1 | 13 |
| Harry H Penner, Jr. | 1 | 6 |
| Larry Dillaha | 1 | 3 |
| Scott Kozak | 1 | 2 |
| Theodore H. Stanley | 1 | 2 |
| Patrick Fourteau | 1 | 2 |
| Larry H. Dillaha | 1 | 2 |
| Patrick H. Fourteau | 1 | 2 |
| Christopher H. Ecklund | 1 | 1 |
| Harry Penner, Jr. | 1 | 1 |
| Nancy Motola | 1 | 1 |
| William Sessa | 1 | 1 |
| William H. Sessa | 1 | 1 |
| Daniel H. Wagner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.